Drug susceptibility in emerging fungal infections: tests with fluconazole, itraconazole, and amphotericin B
An. bras. dermatol
; 93(3): 462-464, May-June 2018. tab
Article
en En
| LILACS
| ID: biblio-1038269
Biblioteca responsable:
BR1.1
ABSTRACT
Abstract The number of new cases of emerging fungal infections has increased considerably in recent years, mainly due to the large number of immunocompromised individuals. The objective of this study was to evaluate the susceptibility of emerging fungi to fluconazole, itraconazole and amphotericin B by disk diffusion method. In 2015, 82 emerging fungi were evaluated in IPB-LACEN/RS and 13 (15.8%) were resistant 10/52 were from superficial mycoses and 3/30 from systemic mycoses. The data from the study point to the need for permanent vigilance regarding the careful evaluation in the prescription and clinical and laboratory follow-up of patients affected by fungal infections.
Palabras clave
Texto completo:
1
Índice:
LILACS
Asunto principal:
Farmacorresistencia Fúngica
/
Hongos
/
Antifúngicos
Tipo de estudio:
Incidence_studies
Límite:
Adult
/
Aged
/
Female
/
Humans
/
Male
Idioma:
En
Revista:
An. bras. dermatol
Asunto de la revista:
DERMATOLOGIA
Año:
2018
Tipo del documento:
Article